Johnson & Johnson Announces Second Major Project In North Carolina Due To Agreement With The Trump Administration
Last week, Johnson & Johnson announced plans to expand its presence in North Carolina with an additional multibillion dollar investment in its project near Wilson, NC. The company plans to create over 500 additional jobs and increase investment in North Carolina by $2 billion. This agreement comes after a joint agreement with the Trump administration.
“Today’s agreement shows that when the public and private sectors work together towards shared goals, we can deliver real results for patients and the U.S. economy,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “I’m proud that Johnson & Johnson is answering President Trump’s call to lower drug prices for everyday Americans while maintaining our role in improving and saving lives and ensuring that the United States continues to lead the world in healthcare innovation.”
Improving Access and Lowering Costs for U.S. Patients
Johnson & Johnson is working with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The Company is:
Participating in TrumpRx.gov, a direct to patient platform, which will allow millions of American patients to purchase medicines from Johnson & Johnson at significantly discounted rates.
Enabling American patients to access medicines at comparable prices to other developed countries.
Providing Medicaid program access at comparable prices to other developed countries.
Continuing to support the Administration’s efforts to ensure better recognition of the value of health care across developed markets globally.
As part of the new agreement, the company announced two new manufacturing plants, including the $2 billion biologics manufacturing facility in Wilson, North Carolina. In October 2024, J&J announced its first project in Wilson, a $2 billion investment that will create 420 jobs on a pharmaceutical manufacturing campus for innovative biologics. Construction of that facility is underway, and the company reports it is already ramping up the hiring of advanced manufacturing employees. In August 2025, the company secured a new 160,000-square-foot site in Holly Springs dedicated to biopharmaceutical manufacturing. That $2 billion commitment over the next 10 years will create 120 new jobs, according to the company.
“We are pleased to make another significant manufacturing investment in North Carolina. This new facility is the third North Carolina project announced by Johnson & Johnson in the past year and will help to further accelerate the delivery of our portfolio of transformational medicines for patients,” said Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine, Johnson & Johnson. “North Carolina is an important life sciences hub, and we look forward to increasing our presence in the state.”
J&J’s new Wilson project will be supported by an expected legislative appropriation of $12 million to expand the training center at Wilson Community College. A grant from the state’s Industrial Development Fund – Utility Account is also expected.
“Once again, Johnson & Johnson—healthcare’s leading, most comprehensive, and innovative powerhouse—has recognized the value of doing business in North Carolina, and specifically in Wilson County,” said N.C. Senator Buck Newton. “North Carolina’s low tax environment and our investment in the Best Center at the Wilson Community College continues to attract new, high paying jobs to the region. This major investment in a new top-tier manufacturing operation underscores Johnson & Johnson’s confidence in Wilson and our state and is a big part of its commitment to invest $55 billion in new U.S. manufacturing, research and development, and advanced technology.”
